Back to search
Human Immunodeficiency Virus 1 Positive
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Human Immunodeficiency Virus 1 Positive trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Human Immunodeficiency Virus 1 Positive trials you may qualify forThe purpose of this study is to evaluate the safety and immunogenicity of MTBVAC in adolescents and adults living with and without HIV in South Africa
Randomized phase II clinical trial which aims to assess the impact on 3-month mortality and safety of adding adalimumab to standard treatment (anti-tuberculosis…
Unicenter, open-label, randomized, noninferiority trial included men with HIV-1 RNA levels \<50 copies/ml for at least 6 months on antiretroviral therapy with D…
The aim of this study is to monitor virological and immunological markers in participants who are switching from a classic triple drug regimen (3DR) to dual the…
Cervical cancer disproportionately affects women in low- and middle-income countries (LMICs), particularly women living with HIV (WLWH) who have a 6-fold increa…
This phase II clinical trial studies the side effects of pomalidomide and how well it works in treating patients with Kaposi sarcoma and human immunodeficiency…